Explore
Featured
Recent
Articles
Topics
Login
Upload
Featured
Recent
Articles
Topics
Login
Upload
Search Results for 'hiv trial'
hiv trial published presentations and documents on DocSlides.
Recruitment of Female Sex Workers in HIV Prevention Trials: Can Efficacy Endpoints Be Reached More Efficiently?
by tawny-fly
Recruitment of Female Sex Workers in HIV Preventi...
Ledipasvir-Sofosbuvir in GT1 or GT4 and HIV Coinfection
by pasty-toler
ION-4. Phase . 3. Treatment. Naïve and Treatmen...
Progress in the HIV Vaccine Field
by eatsui
Larry Corey, MD. Principal Investigator, NIAID sup...
Estimating the impact of improvements in the HIV care cascade on HIV incidence among men
by yoshiko-marsland
who have sex with men in the US: mathematical mod...
New Prevention Technologies Workshop
by alexa-scheidler
Module 6: . Ethics. www.icad-cisd.com. HUMAN RIGH...
Stakeholder Engagement in cure research
by tatyana-admore
HIV Cure Research Training Curriculum. Stakeholde...
New Prevention Technologies Workshop
by sherrill-nordquist
Module 3: Overview of Prevention Research. www.ic...
Regulatory issues in HIV cure Research
by debby-jeon
HIV Cure Research Training Curriculum. Regulatory...
HIV Pre-Exposure Prophylaxis (
by cheryl-pisano
PrEP. ). Yuma Health District 5/23/16. Alyssa Gui...
Economic evaluation of non-financial incentives to increase Couples HIV Testing & Counselling u
by jane-oiler
Mangenah C. , . Sibanda. E, . Hatzold. K, . Mar...
Pre-exposure Prophylaxis for HIV Prevention
by pamella-moone
Efficacy and the importance of adherence. Joanne ...
Increasing knowledge of HIV status among men: a cluster-randomised trial of community-based distrib
by yoshiko-marsland
H. Ayles. 1,2. , S. Floyd. 3. , C. Mulubwa. 2. , ...
Methods Data for this NIDA-funded HIV prevention trial (Project WORTH) were drawn from
by enteringmalboro
trichomoniasis. ). Multiple logistic regression an...
Standard of Care HIV/AIDS Research
by joedanone
Sheela Godbole MD. National AIDS Research Institut...
Project: HIV RT inhibition
by callie
PREVIOUS PRESENTATION: HIV BIOLOGY and PROJECT BAS...
CHIDAMIDE DISRUPTS AND REDUCES HIV-1 LATENCY IN PATIENTS ON SUPPRESSIVE ANTIRETROVIRAL THERAPY
by sophie
Y. . S. un, J. Li, J. Ma, C. Wang, F. Bai, K. Zhao...
Introduction HIV+ smokers are less successful with quit attempts compared to uninfected smokers pot
by melanie
depression and dysthymia exceedingly common in HIV...
Heidi Müller 1 *, Johan De Decker
by paisley
1. *, . Karen Buleza. 2. *, Siew Pin Chai. 3. , An...
Augustine Choko , Charles
by tatyana-admore
Weijer. , Elizabeth . Corbett, Katherine . Fieldi...
A Community Perspective on SMART
by test
Richard Jefferys. Coordinator, Michael . Palm Bas...
Viral and Host characteristics of a child with perinatal HIV-1 after prolonged period of ART cessat
by tawny-fly
Avy . Violari, . Mark . Cotton, . Louise . Kuhn, ...
A two-arm (proof of concept) randomised phase II trial Vorinostat plus a prime boost Vaccine
by alexa-scheidler
A-899-0059-12977. Presented by Professor Sarah Fi...
Paramesh Chetty
by lindy-dunigan
1. , Gwynn Stevens. 1. ,. . Bashir Farah. 2. , I...
Clinical Trial of antiretroviral effects of the Medicinal S
by alexa-scheidler
. . M. C. O. . Ezeibe. an...
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Ledipasvir-Sofosbuvir in GT-1
by faustina-dinatale
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Daclatasvir
by trish-goza
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Daclatasvir
by giovanna-bartolotta
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Vaccins anti-VIH: un d fi!
by opelogen
Vaccins anti VIH. : un développement . complexe...
Policy on PrEP in SRH services and trials:
by briana-ranney
The . South African experience. Sinead Delany-Mor...
Table ronde Comorbidités
by tatyana-admore
Immunologie et VIH. Impact de la PREP . sur. la ...
How to assess the efficacy of new strategies for the prevention of HIV – experience from the HVTN
by tawny-fly
Sinead Delany-Moretlwe. Wits RHI, University of t...
A Phase I/II Trial of the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and
by warlikebikers
IMPAACT . 2001 STUDY . Mhembere T.P. (B. Pharm . (...
Additional copies are available from Office of Communications Divisi
by catherine
TABLE OF CONTENTS BACKGROUND ........................
Passive and Active Immunization
by hailey
Nono Mkhize, PhD. National Institute for Communica...
Dr . N. Kumarasamy Chief & Director
by bency
VHS- Infectious Diseases Medical Centre. Director/...
New Science, New Hope: Giving Women Power Over
by joyce
AIDS. The John Kevany Memorial Lecture. Zeda Rosen...
1 1 : Programme PAC-CI, ANRS
by lois-ondreau
research. site, Abidjan, Côte d’Ivoire. 2 : ...
The 12-Dose INH-Rifapentine Once-Weekly DOT Regimen:
by briana-ranney
What Next?. CTCA Conference 2012. John Jereb, FSE...
Basic statistics
by celsa-spraggs
European Molecular Biology Laboratory. Predoc. B...
Load More...
